These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35981125)

  • 1. Out-of-pocket spending for health care after COVID-19 hospitalization.
    Chua KP; Conti RM; Becker NV
    Am J Manag Care; 2022 Aug; 28(8):398-402. PubMed ID: 35981125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020.
    Chua KP; Conti RM; Becker NV
    JAMA Netw Open; 2021 Oct; 4(10):e2129894. PubMed ID: 34661662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Out-of-Pocket Spending Within 90 Days of Discharge from COVID-19 Hospitalization.
    Chua KP; Conti RM; Becker NV
    medRxiv; 2021 Jun; ():. PubMed ID: 34159340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out-of-Pocket Spending for Influenza Hospitalizations in Medicare Advantage.
    Chua KP; Conti RM
    Am J Prev Med; 2021 Apr; 60(4):537-541. PubMed ID: 33612337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-Pocket Spending for Hospitalizations Among Nonelderly Adults.
    Adrion ER; Ryan AM; Seltzer AC; Chen LM; Ayanian JZ; Nallamothu BK
    JAMA Intern Med; 2016 Sep; 176(9):1325-32. PubMed ID: 27367932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Out-of-Pocket Spending for Non-Birth-Related Hospitalizations of Privately Insured US Children, 2017 to 2019.
    Carlton EF; Becker NV; Moniz MH; Scott JW; Prescott HC; Chua KP
    JAMA Pediatr; 2023 May; 177(5):516-525. PubMed ID: 36972040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB; Huskamp HA; Winn AN; Basch E; Keating NL
    JAMA Oncol; 2018 Jun; 4(6):e173598. PubMed ID: 29121177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Medicare Advantage Enrollment With Financial Burden of Care : A Retrospective Cohort Study.
    Park S; Meyers DJ; Trivedi AN
    Ann Intern Med; 2024 Jul; 177(7):882-891. PubMed ID: 38914004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Financial Risk for COVID-19-like Respiratory Hospitalizations in Consumer-Directed Health Plans.
    Eisenberg MD; Barry CL; Schilling CL; Kennedy-Hendricks A
    Am J Prev Med; 2020 Sep; 59(3):445-448. PubMed ID: 32703700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer.
    Narang AK; Nicholas LH
    JAMA Oncol; 2017 Jun; 3(6):757-765. PubMed ID: 27893028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance.
    DiStefano MJ; Kang SY; Parasrampuria S; Anderson GF
    JAMA Health Forum; 2023 May; 4(5):e231090. PubMed ID: 37234016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rising Use Of Observation Care Among The Commercially Insured May Lead to Total And Out-Of-Pocket Cost Savings.
    Adrion ER; Kocher KE; Nallamothu BK; Ryan AM
    Health Aff (Millwood); 2017 Dec; 36(12):2102-2109. PubMed ID: 29200335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Relative Importance of Post-Acute Care and Readmissions for Post-Discharge Spending.
    Huckfeldt PJ; Mehrotra A; Hussey PS
    Health Serv Res; 2016 Oct; 51(5):1919-38. PubMed ID: 26841171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a Claims-Based Frailty Index to Investigate Frailty, Survival, and Healthcare Expenditures among Older Adults Hospitalized for COVID-19 at an Academic Medical Center.
    Keeney T; Flom M; Ding J; Sy M; Leung K; Kim DH; Orav J; Vogeli C; Ritchie CS
    J Frailty Aging; 2023; 12(2):150-154. PubMed ID: 36946713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual Out-Of-Pocket Spending Clusters Within Short Time Intervals: Implications For Health Care Affordability.
    Chen S; Shafer PR; Dusetzina SB; Horný M
    Health Aff (Millwood); 2021 Feb; 40(2):274-280. PubMed ID: 33523742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps.
    Dusetzina SB; Huskamp HA; Jazowski SA; Winn AN; Basch E; Keating NL
    JAMA Health Forum; 2021 May; 2(5):e210673. PubMed ID: 35977314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient cost sharing during poly(adenosine diphosphate-ribose) polymerase inhibitor treatment in ovarian cancer.
    Harrison RF; Fu S; Sun CC; Zhao H; Lu KH; Giordano SH; Meyer LA
    Am J Obstet Gynecol; 2021 Jul; 225(1):68.e1-68.e11. PubMed ID: 33549538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs.
    Rome BN; Feldman WB; Desai RJ; Kesselheim AS
    JAMA Netw Open; 2021 May; 4(5):e218816. PubMed ID: 33944925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.